Tracon's Promising Tumor Treatments Make The Stock A Buy
Ophthotech's Fovista Has Potential To Break Through The 'Therapeutic Ceiling' Of Anti-VEGF Therapies
Expect Merrimack Pharma Shares To Be Range-Bound For The Near Term
Acceleron Has 2 Phase III Trials With Good Chance Of Success; BTIG Initiates Stock At Buy
Ling Wang Recent News
Why Oppenheimer Still Thinks Rockwell Medical Could Double
35 Stock Ideas Oppenheimer Analysts Love Right Now
8 Oppenheimer Analysts Choose Their Favorite Healthcare Stocks
UPDATE: Oppenheimer Initiates Coverage On Rockwell Medical On Significant Expected Upside
Brean Murray Carret & Co. Maintains Buy Rating On ImmunoGen, Inc. (IMGN)
Brean Murray Carret Reiterates Buy On Immunogen (IMGN)